梅安森(300275) - 2025 Q3 - 季度财报

Financial Performance - Revenue for Q3 2025 was CNY 94,780,657.78, a decrease of 20.76% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 10,866,845.59, down 22.91% year-on-year[5] - Basic earnings per share decreased by 24.63% to CNY 0.0352[5] - Total operating revenue decreased to ¥317,443,676.06 from ¥351,926,904.02, a decline of approximately 9.8%[26] - Net profit for the period was ¥39,724,457.99, down from ¥46,549,571.20, representing a decrease of about 14.0%[27] - Basic earnings per share decreased to ¥0.1294 from ¥0.1537, a decline of about 15.7%[27] Cash Flow and Liquidity - Cash flow from operating activities showed a net outflow of CNY 14,390,746.77, a decline of 414.54% compared to the previous year[13] - Operating cash flow net amount was negative at ¥-14,390,746.77, compared to a positive ¥4,575,169.57 in the previous period[30] - The company's cash and cash equivalents decreased to CNY 30,938,521.71 from CNY 76,501,485.30, reflecting a significant reduction in liquidity[21] - The ending balance of cash and cash equivalents was $24.46 million, down from $26.81 million in the previous period[31] - The net increase in cash and cash equivalents was -$42.14 million, compared to -$82.39 million in the previous period, showing a significant reduction in cash burn[31] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,332,563,415.96, a decrease of 1.15% from the end of the previous year[5] - The total assets of the company as of September 30, 2025, amounted to CNY 1,332,563,415.96, a decrease from CNY 1,348,073,309.76 at the beginning of the period[21] - Total liabilities decreased to ¥390,052,408.31 from ¥454,076,427.16, a reduction of approximately 14.1%[23] - The company's total current liabilities decreased to CNY 356,846,020.20 from CNY 380,564,127.89, indicating improved short-term financial health[22] Shareholder Equity - The company's equity attributable to shareholders increased by 5.41% to CNY 942,150,886.31 compared to the end of the previous year[5] - Total equity attributable to shareholders increased to ¥942,150,886.31 from ¥893,766,563.64, an increase of about 5.4%[23] - The total number of restricted shares at the end of the period was 36,543,615, with significant releases planned for certain shareholders[18] - The company has a total of 2,680,900 shares held in a repurchase account, indicating ongoing share buyback activities[17] Receivables and Inventory - Accounts receivable increased to CNY 436,892,022.96 from CNY 416,851,857.50, indicating a growth in credit sales[21] - Inventory levels rose to CNY 164,331,157.35 from CNY 155,808,758.20, suggesting an increase in stock[21] - The company reported a significant increase in receivables financing by 123.68% to CNY 32,188,262.68[10] Expenses and Impairments - Financial expenses decreased by 52.98% to CNY 2,154,642.98 due to reduced borrowing costs[12] - The company experienced a 50.30% increase in credit impairment losses, totaling CNY -7,423,758.84[12] - The company reported a credit impairment loss of ¥-7,423,758.84, compared to ¥-4,939,456.69 in the previous period, indicating a worsening in credit quality[26] - Research and development expenses increased to ¥34,406,080.06 from ¥31,972,540.21, an increase of approximately 13.6%[26] Future Outlook and Changes - The third quarter financial report was not audited, which may affect the reliability of the reported figures[32] - The company will implement new accounting standards starting in 2025, which may impact future financial reporting[32]